{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:31:16Z","timestamp":1790418676533,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Enlight Biosciences"},{"name":"Otis Williams Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10439-016-1558-x","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T22:51:25Z","timestamp":1455144685000},"page":"1993-2007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices"],"prefix":"10.1007","volume":"44","author":[{"given":"Vivek","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishit","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron C.","family":"Anselmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mitragotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"1558_CR1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2013.05.031","volume":"170","author":"S Ahn","year":"2013","unstructured":"Ahn, S., I. H. Lee, E. Lee, H. Kim, Y. C. Kim, and S. Jon. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan. J. Control Release 170:226\u2013232, 2013.","journal-title":"J. Control Release"},{"key":"1558_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2015.07.025","volume":"215","author":"MM Al-Tabakha","year":"2015","unstructured":"Al-Tabakha, M. M. Future prospect of insulin inhalation for diabetic patients: the case of Afrezza versus Exubera. J. Control Release 215:25\u201338, 2015.","journal-title":"J. Control Release"},{"key":"1558_CR3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2011. Diab. Care 34: S11\u2013S61, 2011.","DOI":"10.2337\/dc11-S011"},{"key":"1558_CR4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(15)00097-2","volume":"3","author":"A Cahn","year":"2015","unstructured":"Cahn, A., R. Miccoli, A. Dardano, and S. Del Prato. New forms of insulin and insulin therapies for the treatment of type 2 diabetes. Lancet Diabetes Endocrinol. 3:638\u2013652, 2015.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1558_CR5","first-page":"317","volume":"6","author":"G Camenisch","year":"1998","unstructured":"Camenisch, G., J. Alsenz, H. van de Waterbeemd, and G. Folkers. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs\u2019 lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6:317\u2013324, 1998.","journal-title":"Eur. J. Pharm. Sci."},{"key":"1558_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567201811310010005","volume":"10","author":"CM Caramella","year":"2013","unstructured":"Caramella, C. M., G. Sandri, S. Rossi, M. Mori, M. Cristina Bonferoni, F. Ferrari, C. Del Fante, and C. Perotti. New therapeutic platforms for the treatment of epithelial and cutaneous lesions. Curr. Drug Deliv. 10:18\u201331, 2013.","journal-title":"Curr. Drug Deliv."},{"key":"1558_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.05.258","volume":"211","author":"PM Castro","year":"2015","unstructured":"Castro, P. M., P. Fonte, F. Sousa, A. R. Madureira, B. Sarmento, and M. E. Pintado. Oral films as breakthrough tools for oral delivery of proteins\/peptides. J. Control Release 211:63\u201373, 2015.","journal-title":"J. Control Release"},{"key":"1558_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4158\/EP14252.OR","volume":"21","author":"AP Cemeroglu","year":"2015","unstructured":"Cemeroglu, A. P., A. Can, A. T. Davis, O. Cemeroglu, L. Kleis, M. S. Daniel, J. Bustraan, and T. J. Koehler. Fear of needles in children with type 1 diabetes mellitus on multiple daily injections and continuous subcutaneous insulin infusion. Endocr. Pract. 21:46\u201353, 2015.","journal-title":"Endocr. Pract."},{"key":"1558_CR9","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.1152\/ajpendo.00030.2008","volume":"294","author":"A Cervera","year":"2008","unstructured":"Cervera, A., E. Wajcberg, A. Sriwijitkamol, M. Fernandez, P. Zuo, C. Triplitt, N. Musi, R. A. DeFronzo, and E. Cersosimo. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 294:E846\u2013E852, 2008.","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1558_CR10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2217\/nnm.15.36","volume":"10","author":"K Chaturvedi","year":"2015","unstructured":"Chaturvedi, K., K. Ganguly, A. R. Kulkarni, W. E. Rudzinski, L. Krauss, M. N. Nadagouda, and T. M. Aminabhavi. Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles. Nanomedicine (Lond) 10:1569\u20131583, 2015.","journal-title":"Nanomedicine (Lond)"},{"key":"1558_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.06.035","volume":"64","author":"EY Chuang","year":"2015","unstructured":"Chuang, E. Y., K. J. Lin, P. Y. Lin, H. L. Chen, S. P. Wey, F. L. Mi, H. C. Hsiao, C. T. Chen, and H. W. Sung. Self-assembling bubble carriers for oral protein delivery. Biomaterials 64:115\u2013124, 2015.","journal-title":"Biomaterials"},{"key":"1558_CR12","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1016\/j.biomaterials.2013.07.021","volume":"34","author":"EY Chuang","year":"2013","unstructured":"Chuang, E. Y., G. T. Nguyen, F. Y. Su, K. J. Lin, C. T. Chen, F. L. Mi, T. C. Yen, J. H. Juang, and H. W. Sung. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT. Biomaterials 34:7994\u20138001, 2013.","journal-title":"Biomaterials"},{"key":"1558_CR13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","volume":"33","author":"P Fonte","year":"2015","unstructured":"Fonte, P., F. Araujo, C. Silva, C. Pereira, S. Reis, H. A. Santos, and B. Sarmento. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol. Adv. 33:1342\u20131354, 2015.","journal-title":"Biotechnol. Adv."},{"key":"1558_CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13300-013-0034-y","volume":"4","author":"LE Garcia-Perez","year":"2013","unstructured":"Garcia-Perez, L. E., M. Alvarez, T. Dilla, V. Gil-Guillen, and D. Orozco-Beltran. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 4:175\u2013194, 2013.","journal-title":"Diabetes Ther."},{"issue":"Suppl 1","key":"1558_CR15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/dmrr.207","volume":"18","author":"J Gordon Still","year":"2002","unstructured":"Gordon Still, J. Development of oral insulin: progress and current status. Diabetes Metab. Res. Rev. 18(Suppl 1):S29\u2013S37, 2002.","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1558_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2221-1691(13)60192-6","volume":"3","author":"P Govindasamy","year":"2013","unstructured":"Govindasamy, P., B. R. Kesavan, and J. K. Narasimha. Formulation of unidirectional release buccal patches of carbamazepine and study of permeation through porcine buccal mucosa. Asian Pac. J. Trop. Biomed. 3:995\u20131002, 2013.","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"1558_CR17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201811666140118225021","volume":"11","author":"M Grover","year":"2014","unstructured":"Grover, M., and P. Utreja. Recent advances in drug delivery systems for anti-diabetic drugs: a review. Curr. Drug Deliv. 11:444\u2013457, 2014.","journal-title":"Curr. Drug Deliv."},{"key":"1558_CR18","doi-asserted-by":"crossref","first-page":"e57136","DOI":"10.1371\/journal.pone.0057136","volume":"8","author":"V Gupta","year":"2013","unstructured":"Gupta, V., N. Doshi, and S. Mitragotri. Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system. PLoS One 8:e57136, 2013.","journal-title":"PLoS One"},{"key":"1558_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jconrel.2013.05.002","volume":"172","author":"V Gupta","year":"2013","unstructured":"Gupta, V., B. H. Hwang, N. Doshi, and S. Mitragotri. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. J. Control Release 172:541\u2013549, 2013.","journal-title":"J. Control Release"},{"key":"1558_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jconrel.2013.09.004","volume":"172","author":"V Gupta","year":"2013","unstructured":"Gupta, V., B. H. Hwang, J. Lee, A. C. Anselmo, N. Doshi, and S. Mitragotri. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. J Control Release 172:753\u2013762, 2013.","journal-title":"J Control Release"},{"key":"1558_CR21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijpharm.2015.08.004","volume":"493","author":"H He","year":"2015","unstructured":"He, H., P. Wang, C. Cai, R. Yang, and X. Tang. VB-coated Gel-Core-SLN containing insulin: another way to improve oral absorption. Int. J. Pharm. 493:451\u2013459, 2015.","journal-title":"Int. J. Pharm."},{"key":"1558_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2015.00092","volume":"9","author":"KM Heppner","year":"2015","unstructured":"Heppner, K. M., and D. Perez-Tilve. GLP-1 based therapeutics: simultaneously combating T2DM and obesity. Front. Neurosci. 9:92, 2015.","journal-title":"Front. Neurosci."},{"key":"1558_CR23","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","volume":"2","author":"I Hubatsch","year":"2007","unstructured":"Hubatsch, I., E. G. Ragnarsson, and P. Artursson. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2:2111\u20132119, 2007.","journal-title":"Nat. Protoc."},{"key":"1558_CR24","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.18295\/2075-0528.1577","volume":"14","author":"B Jimmy","year":"2014","unstructured":"Jimmy, B., J. Jose, Z. A. Al-Hinai, I. K. Wadair, and G. H. Al-Amri. Adherence to medications among Type 2 diabetes mellitus patients in three districts of Al Dakhliyah Governorate, Oman: A cross-sectional pilot study. Sultan Qaboos Univ. Med. J. 14:e231\u2013e235, 2014.","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"1558_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-003-1190-9","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3\u201319, 2003.","journal-title":"Diabetologia"},{"key":"1558_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2015.04.013","volume":"97","author":"T Karamanidou","year":"2015","unstructured":"Karamanidou, T., K. Karidi, V. Bourganis, K. Kontonikola, O. Kammona, and C. Kiparissides. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur. J. Pharm. Biopharm. 97:223\u2013229, 2015.","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1558_CR27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","volume":"59","author":"S Khafagy el","year":"2007","unstructured":"Khafagy el, S., M. Morishita, Y. Onuki, and K. Takayama. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 59:1521\u20131546, 2007.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1558_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/tde.14.92","volume":"6","author":"M Lopes","year":"2015","unstructured":"Lopes, M., S. Simoes, F. Veiga, R. Seica, and A. Ribeiro. Why most oral insulin formulations do not reach clinical trials. Ther. Deliv. 6:1\u201315, 2015.","journal-title":"Ther. Deliv."},{"key":"1558_CR29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1208\/s12249-014-0282-9","volume":"16","author":"M Mansourpour","year":"2015","unstructured":"Mansourpour, M., R. Mahjub, M. Amini, S. N. Ostad, E. S. Shamsa, M. Rafiee-Tehrani, and F. A. Dorkoosh. Development of acid-resistant alginate\/trimethyl chitosan nanoparticles containing cationic beta-cyclodextrin polymers for insulin oral delivery. AAPS PharmSciTech 16:952\u2013962, 2015.","journal-title":"AAPS PharmSciTech"},{"key":"1558_CR30","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1002\/jps.24142","volume":"103","author":"L Mazzarino","year":"2014","unstructured":"Mazzarino, L., R. Borsali, and E. Lemos-Senna. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release. J. Pharm. Sci. 103:3764\u20133771, 2014.","journal-title":"J. Pharm. Sci."},{"key":"1558_CR31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","volume":"11","author":"M Morishita","year":"2006","unstructured":"Morishita, M., and N. A. Peppas. Is the oral route possible for peptide and protein drug delivery? Drug Discov. Today 11:905\u2013910, 2006.","journal-title":"Drug Discov. Today"},{"key":"1558_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","volume":"189","author":"EJ Nielsen","year":"2014","unstructured":"Nielsen, E. J., S. Yoshida, N. Kamei, R. Iwamae, S. Khafagy el, J. Olsen, U. L. Rahbek, B. L. Pedersen, K. Takayama, and M. Takeda-Morishita. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin. J. Control Release 189:19\u201324, 2014.","journal-title":"J. Control Release"},{"key":"1558_CR33","first-page":"53","volume":"2","author":"KK Peh","year":"1999","unstructured":"Peh, K. K., and C. F. Wong. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J. Pharm. Pharm. Sci. 2:53\u201361, 1999.","journal-title":"J. Pharm. Pharm. Sci."},{"key":"1558_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0169-409X(98)00040-4","volume":"34","author":"G Ponchel","year":"1998","unstructured":"Ponchel, G., and J. Irache. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:191\u2013219, 1998.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1558_CR35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz, M. R., and R. Langer. Transdermal drug delivery. Nat. Biotechnol. 26:1261\u20131268, 2008.","journal-title":"Nat. Biotechnol."},{"key":"1558_CR36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","volume":"440","author":"MR Rekha","year":"2013","unstructured":"Rekha, M. R., and C. P. Sharma. Oral delivery of therapeutic protein\/peptide for diabetes\u2013future perspectives. Int. J. Pharm. 440:48\u201362, 2013.","journal-title":"Int. J. Pharm."},{"key":"1558_CR37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(98)00044-3","volume":"55","author":"C Remunan-Lopez","year":"1998","unstructured":"Remunan-Lopez, C., A. Portero, J. L. Vila-Jato, and M. J. Alonso. Design and evaluation of chitosan\/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control Release 55:143\u2013152, 1998.","journal-title":"J. Control Release"},{"key":"1558_CR38","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","volume":"7","author":"J Sheng","year":"2015","unstructured":"Sheng, J., L. Han, J. Qin, G. Ru, R. Li, L. Wu, D. Cui, P. Yang, Y. He, and J. Wang. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. ACS Appl. Mater. Interfaces 7:15430\u201315441, 2015.","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1558_CR39","doi-asserted-by":"crossref","first-page":"A612","DOI":"10.1016\/j.jval.2015.09.2122","volume":"18","author":"A Sicras-Mainar","year":"2015","unstructured":"Sicras-Mainar, A., R. Navarro, L. Ruiz, and R. Morano. Adherence and persistence in patients initiating treatment with injectable therapies for Type 2 diabetes mellitus (T2\u00a0dm) in Spain. Value Health 18:A612, 2015.","journal-title":"Value Health"},{"key":"1558_CR40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","volume":"57","author":"JD Smart","year":"2005","unstructured":"Smart, J. D. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. 57:1556\u20131568, 2005.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1558_CR41","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2147\/IJN.S81715","volume":"10","author":"S Sun","year":"2015","unstructured":"Sun, S., N. Liang, H. Yamamoto, Y. Kawashima, F. Cui, and P. Yan. pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin. Int. J. Nanomed. 10:3489\u20133498, 2015.","journal-title":"Int. J. Nanomed."},{"key":"1558_CR42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijpharm.2014.07.039","volume":"473","author":"C Tang","year":"2014","unstructured":"Tang, C., Y. X. Guan, S. J. Yao, and Z. Q. Zhu. Preparation of ibuprofen-loaded chitosan films for oral mucosal drug delivery using supercritical solution impregnation. Int. J. Pharm. 473:434\u2013441, 2014.","journal-title":"Int. J. Pharm."},{"key":"1558_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjopharm.2011.02.006","volume":"9","author":"LK Tanwani","year":"2011","unstructured":"Tanwani, L. K. Insulin therapy in the elderly patient with diabetes. Am. J. Geriatr. Pharmacother. 9:24\u201336, 2011.","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"1558_CR44","first-page":"518","volume":"60","author":"F Tirnaksiz","year":"2005","unstructured":"Tirnaksiz, F., and J. R. Robinson. Rheological, mucoadhesive and release properties of pluronic F-127 gel and pluronic F-127\/polycarbophil mixed gel systems. Pharmazie 60:518\u2013523, 2005.","journal-title":"Pharmazie"},{"key":"1558_CR45","unstructured":"Usansky J., A. Desai, and T.-L. D. PK functions for Microsoft Excel. 2003."},{"key":"1558_CR46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2008.03.005","volume":"128","author":"K Whitehead","year":"2008","unstructured":"Whitehead, K., N. Karr, and S. Mitragotri. Discovery of synergistic permeation enhancers for oral drug delivery. J. Control Release 128:128\u2013133, 2008.","journal-title":"J. Control Release"},{"key":"1558_CR47","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11095-007-9488-9","volume":"25","author":"K Whitehead","year":"2008","unstructured":"Whitehead, K., N. Karr, and S. Mitragotri. Safe and effective permeation enhancers for oral drug delivery. Pharm. Res. 25:1782\u20131788, 2008.","journal-title":"Pharm. Res."},{"key":"1558_CR48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","volume":"98","author":"K Whitehead","year":"2004","unstructured":"Whitehead, K., Z. Shen, and S. Mitragotri. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J. Control Release 98:37\u201345, 2004.","journal-title":"J. Control Release"},{"key":"1558_CR49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(98)00402-5","volume":"180","author":"CF Wong","year":"1999","unstructured":"Wong, C. F., K. H. Yuen, and K. K. Peh. An in vitro method for buccal adhesion studies: importance of instrument variables. Int. J. Pharm. 180:47\u201357, 1999.","journal-title":"Int. J. Pharm."},{"key":"1558_CR50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2013.05.035","volume":"170","author":"Q Xu","year":"2013","unstructured":"Xu, Q., N. J. Boylan, S. Cai, B. Miao, H. Patel, and J. Hanes. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. J. Control Release 170:279\u2013286, 2013.","journal-title":"J. Control Release"},{"key":"1558_CR51","first-page":"623","volume":"35","author":"L Yim","year":"2006","unstructured":"Yim, L. Belonephobia\u2014a fear of needles. Aust. Fam. Phys. 35:623\u2013624, 2006.","journal-title":"Aust. Fam. Phys."},{"key":"1558_CR52","doi-asserted-by":"crossref","first-page":"e86064","DOI":"10.1371\/journal.pone.0086064","volume":"9","author":"B Zhang","year":"2014","unstructured":"Zhang, B., D. He, Y. Fan, N. Liu, and Y. Chen. Oral delivery of exenatide via microspheres prepared by cross-linking of alginate and hyaluronate. PLoS One 9:e86064, 2014.","journal-title":"PLoS One"},{"key":"1558_CR53","doi-asserted-by":"crossref","unstructured":"Zhu S., S. Chen, Y. Gao, F. Guo, F. Li, B. Xie, J. Zhou and H. Zhong. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec). Drug Deliv 1\u201312, 2015.","DOI":"10.3109\/10717544.2015.1101791"}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-016-1558-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10439-016-1558-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-016-1558-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:34:53Z","timestamp":1748774093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10439-016-1558-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1007\/s10439-016-1558-x","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}